The anti-cholesterol drug Praluent (alirocumab), made by France’s Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday. Alirocumab was also associated with a 15 percent reduction in death from any cause...
mrsam
Thread
anti-cholesterol
drug
metro news today 110318
nigeria news today
punch newspapers
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.